Gene Panel Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Gene Panel Market covers analysis By Product and Service (Testing Services, Test Kits); Technique (Hybridization-Based Approach, Amplicon-Based Approach); Application (Cancer Risk Assessment, Diagnosis of Congenital Disorders, Pharmacogenetics, Other Applications); Design (Customized Gene Panels, Predesigned Gene Panels); End User (Hospitals and Diagnostic Laboratories, Research and Academic Institutes, Pharmaceutical and Biotechnology Companies) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPBT00002182
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET OVERVIEW

A gene panel is a test that is used to analyse multiple genes at once for cancer-associated mutations. The rising prevalence of chronic diseases and increasing technological advancement in diagnostics services and methods are driving the growth of the market. The increasing ongoing research and development in the field of sequencing across also driving the gene panel market.

MARKET SCOPE

The "Global Gene Panel Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Gene Panel market with detailed market segmentation by products & services, technique, design, application, end user and geography. The report provides key statistics on the market status of the leading Gene Panel market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  • Based on products & services, the global gene panel market is segmented into testing services, and test kits.
  • Based on technique, the global gene panel market is segmented into hybridization-based approach, and amplicon-based approach.
  • Based on design, the global gene panel market is segmented into customized gene panels, and predesigned gene panels.
  • Based on application, the global gene panel market is segmented into cancer risk assessment, diagnosis of congenital disorders, pharmacogenetics, other applications.
  • On the basis of end user, the market is segmented into hospitals and diagnostic laboratories, research and academic institutes, and pharmaceutical and biotechnology companies.

MARKET DYNAMICS

Drivers

  • Increasing prevalance of chronic diseases
  • Increasing demand for genetic testing
  • Increasing research and development activities in biotechnology sector
  • Increasing government initiatives in population sequencing

Restraints

  • Accuracy concerns in diagnostic testing

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Gene Panel market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Gene Panel market in these regions.

IMPACT OF COVID-19 ON GENE PANEL MARKET

The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 pandemic has left a significant impact on the growth of the genetic testing services. Most of the genetic testing services have adopted virtualization, along with home testing kit/home sample collection to combat the transmission of the COVID-19. However, there was hindrance in accessing genetic testing blood draws leading to decrease in demand of genetic testing. Thus, negatively impacting the demand for gene panel worldwide.

MARKET PLAYERS

The report covers key developments in the Gene Panel market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Gene Panel market are anticipated to lucrative growth opportunities in the future with the rising demand for Gene Panel in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Gene Panel market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Agilent
  • Qiagen
  • Eurofins Scientific
  • BGI
  • F. Hoffmann-La Roche AG
  • Integrated Dna Technologies
  • Genewiz, Inc.
  • Novogene Corporation

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Gene Panel Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product and Service
  • Testing Services
  • Test Kits
By Technique
  • Hybridization-Based Approach
  • Amplicon-Based Approach
By Application
  • Cancer Risk Assessment
  • Diagnosis of Congenital Disorders
  • Pharmacogenetics
  • Other Applications
By Design
  • Customized Gene Panels
  • Predesigned Gene Panels
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Agilent
  • Qiagen
  • Eurofins Scientific
  • BGI
  • F. Hoffmann-La Roche AG
  • Integrated DNA Technologies
  • Genewiz, Inc.
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    1. Illumina, Inc.
    2. Thermo Fisher Scientific Inc.
    3. Agilent
    4. Qiagen
    5. Eurofins Scientific
    6. BGI
    7. F. Hoffmann-La Roche AG
    8. Integrated DNA Technologies
    9. Genewiz, Inc.
    10. Novogene Corporation
    11. ArcherDx
    12. GATC Biotech AG
    13. Personalis
    14. CENTOGENE N.V.
    15. Myriad Genetics, Inc.


    Buy Now